1152 results
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... since they are not able ... normal range (KDIGO ... hypercalcemia (KDIGO ... Purposes Only* #CKD
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... Kidney Disease (CKD ... per 1.73 m2 • Stable ... /CKD • No structural ... damage #AKI #CKD
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Comorbidities: • Stable ... Dissection • CKD ... , DM, ESRD, PKD ... #pharmacology #table
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... SGLT2i in HF and CKD ... SGLT2i in HF and CKD ... visualabstract #table ... #CVD #CKD
KDIGO Definition of Acute Kidney Injury (AKI)

#Diagnosis #Nephrology #KDIGO #AKI #Acute #Kidney #Injury
KDIGO Definition ... Diagnosis #Nephrology #KDIGO
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... ADA/KDIGO Consensus ... 2 diabetes and CKD ... #Diabetes #CKD # ... ADA #KDIGO #eGFR
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Pharmacology #Opiates #CKD ... #Gabapentin #Table
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Metformin in Diabetic Kidney Disease
Immediate release:
 • Initial 500 mg or 850 mg once daily
 •
#Metformin #CKD ... algorithm #management #kdigo
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... Improved outcomes in CKD ... #medications #table